721 results found
SPRINT: fnirS Platform foR braIn moNiToring, analytics and data repository
Project Overview
Brain-based disorders such as epilepsy, stroke, acquired brain injury, and Parkinson’s Disease impact tens of thousands of Canadians each year. Diagnosis and monitoring of brain-based disorders is done using brainimaging methods including magnetic resonance imaging (MRI) and electroencephalography (EEG). However, these techniques are limited for their use for clinical and…
Project Ongoing
See the project and researchersThe Brain Single Cell Initiative
Project Overview
The recent breakthrough technology of single-cell genomics has vastly improved our capacity to understand how the trillions of cells in our body develop and work together to make us human. This advance combines the power of the microscope, used to discover that all biological organisms are composed of cells, with…
Project Ongoing
See the project and researchersCanStroke Recovery Trials: Platform Expansion Proposal
Project Overview
In 2017, Canada saw 89,500 new strokes in people aged 20 and older and counted 878,500 people living with stroke. Developing innovative therapeutics, devices, and clinical interventions for this population, many of whom experience long-term disability, has been a priority for the stroke community. To evaluate these new approaches, the…
Project Ongoing
See the project and researchersEnabling Neuroscience research Approaches for Brain, feeLings and Emotions (ENABLE): An Platform for Clinical Trials in Mood Disorders
Project Overview
Mood disorders such as depression and bipolar disorder affect over 350 million people around the world. While several effective treatments exist, it is often difficult to match the right treatment to an individual person. Repeated efforts to find the right treatment contribute to poor functioning, low quality of life, and…
Project Ongoing
See the project and researchersThe Neuro’s Virtual Integrated Patient Platform
Project Overview
Patients with neurological disease are understandably frustrated by the lack of meaningful pharmacological treatments for even comparatively common pathologies such as Parkinson’s Disease. One of the common complicating factors for these patients are broad disease labels, such as “Multiple Sclerosis”, which encompass several distinct biological entities under a common but…